Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Cancer Pain 2Brain Neoplasms 2Agnosia 2Urologic Neoplasms 1Surgical Wound Infection 1Smoking 1Risk Reduction Behavior 1Postoperative Complications 1Patient Preference 1Pancreatic Neoplasms 1Pancreatic Mucinous-Cystic Neoplasm 1Pain 1Oligodendroglioma 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Malnutrition 1Inflammatory Bowel Diseases 1Ependymoma 1Diverticulitis 1Condylomata Acuminata 1Colorectal Neoplasms 1Astrocytoma 1Alcohol Drinking 1Abdominal Cancer 1

Interventions

Fluorouracil 18Oxaliplatin 17Capecitabine 16Leucovorin 13Cisplatin 12Gemcitabine 11Drug Therapy 11Irinotecan 10Radiosurgery 9Cetuximab 9Bevacizumab 9pembrolizumab 8Docetaxel 8Everolimus 7spartalizumab 6Sunitinib 6Radiotherapy 6Paclitaxel 6Neoadjuvant Therapy 6Cyclophosphamide 6Trastuzumab 5S 1 (combination) 5Nivolumab 5Immunotherapy 5Immune Checkpoint Inhibitors 5Chemotherapy, Adjuvant 5Carboplatin 5palbociclib 4manganese chloride 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasm Metastasis × Ethanol × Clear all
NCT00009854 2013-11-06

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

National Cancer Institute (NCI)

Phase 1/2 Unknown
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡